BREAKING: Zomato Founder Deepinder Goyal Finds Biomarker That Wearables Have Missed for Years

2026-06-19 · Source: AIM Network · Field: Health & Wellbeing — Medical Devices & Health Technology, Health & Medical Research · Depth: Fundamental Awareness, quick

Summary

Zomato founder Deepinder Goyal, through his company Eternal, has announced the discovery of a new biomarker called "entropy" and a wearable device named Temple. This biomarker measures the "real-time cost of being alive," quantifying the body's metabolic and sympathetic demand on a scale from 1 to 250, where 1 signifies deepest rest and 250 indicates peak strenuous activity. The amoeboid-shaped Temple device, worn on the side of the head, accurately tracks heart rate comparable to a Polar chest band. Goyal claims various factors like sleep, stress, coffee, and exercise influence entropy, linking a pattern of low entropy at rest and high during activity to healthy aging. While Temple is not yet commercially available, early access is offered. Goyal clarifies Temple is separate from his controversial "gravity aging hypothesis," which experts largely dispute, asserting aging affects cerebral blood flow, not the reverse.

Key takeaway

For health tech investors evaluating novel biomarker claims, exercise caution with products like Temple, which introduces "entropy" without disclosed parameters or methodology. While the concept of measuring metabolic demand is intriguing, the lack of scientific validation and expert skepticism regarding related hypotheses, such as the gravity aging theory, suggests a high-risk investment. Prioritize solutions with transparent, peer-reviewed scientific backing to mitigate risks in your portfolio.

Key insights

Zomato founder Deepinder Goyal claims a new biomarker, "entropy," measures metabolic demand, tracked by his Temple device.

Principles

• Entropy reflects metabolic and sympathetic demand.
• Healthy aging links to low rest entropy, high activity entropy.
• Daily factors like sleep, stress, and diet influence metabolic cost.

In practice

• Use wearables to track real-time heart rate.
• Observe how lifestyle choices affect metabolic demand.
• Aim for lower resting entropy, higher activity entropy.

Topics

• Deepinder Goyal
• Temple Device
• Biomarkers
• Wearable Technology
• Metabolic Health
• Gravity Aging Hypothesis

Best for: General Interest, Tech Journalist, Entrepreneur

Related on AIssential

• Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity — A health awakening is driving demand for peptides and advanced bio-interventions, emphasizing individual responsibility and future bio-communication.
• Stress Estimation in Elderly Oncology Patients Using Visual Wearable Representations and Multi-Instance Learning — Wearable data and MIL can estimate perceived stress in oncology patients, offering continuous cardiotoxicity surveillance.
• Two Stanford grads raise $11M to build a noninvasive wearable for hormone tracking — Clair Health offers a noninvasive wearable and AI for continuous, multi-biomarker hormone tracking to empower women's health understanding.
• CogAdapt: Transferring Clinical ECG Foundation Models to Wearable Cognitive Load Assessment via Lead Adaptation — Adapting clinical ECG foundation models via lead transformation and progressive fine-tuning enables robust wearable cognitive load assessment.
• Exclusive: General Catalyst backs YC alum Lucis in $20m Series A — AI-powered preventative health platforms are attracting significant Series A investment, particularly in Europe.
• Beacon Biosignals is mapping the brain during sleep — Monitoring brain activity during sleep with AI-driven EEG offers a scalable path to diagnose and treat neurological disorders.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by AIM Network.